Asset Details
Do you wish to reserve the book?
Development of 18 F-Labeled Deuterated Tropane Derivatives with High Metabolic Stability for PET Imaging of the Dopamine Transporter
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Development of 18 F-Labeled Deuterated Tropane Derivatives with High Metabolic Stability for PET Imaging of the Dopamine Transporter
Do you wish to request the book?
Development of 18 F-Labeled Deuterated Tropane Derivatives with High Metabolic Stability for PET Imaging of the Dopamine Transporter
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Development of 18 F-Labeled Deuterated Tropane Derivatives with High Metabolic Stability for PET Imaging of the Dopamine Transporter
2025
Overview
Dopamine transporter (DAT) in the central nervous system is an attractive biomarker for the diagnosis and study of various neurodegenerative diseases. To develop in vivo metabolically stable positron emission tomography (PET) probes for DAT imaging with a high target/background ratio, two
F-labeled tropane derivatives with deuteration on both the N-fluoropropyl and 2β-carbomethoxy groups of the tropane scaffold were synthesized and evaluated.
Radioligands [
F]6 and [
F]10 were synthesized from anhydroecgonine and radiolabeled with
F through a \"two-step one-pot\" method. Lipophilicity, in vitro binding assay and microPET imaging in rats were performed. [
F]10 showed a higher standardized uptake value ratio (SUVr) and was selected for further evaluations by in vivo metabolism and biodistribution.
The radioligands [
F]6 and [
F]10 were obtained in radiochemical purities > 98% and molar activity of about 30 GBq/μmol. [
F]6 or [
F]10 demonstrated high specificity and binding affinity to DAT in vitro, with IC
values between 2 ~ 3 nM. MicroPET imaging in wild type Sprague-Dawley rats revealed that [
F]10 has a higher SUVr than [
F]6. Blocking experiments demonstrated the selectivity and reversibility of [
F]10 for DAT binding in microPET imaging. The diagnostic efficacy of [
F]10 for DAT-related disorders was verified in semi-PD model rats with microPET. In vivo metabolic studies in rats indicated that [
F]10 exhibited enhanced stability. Biodistribution experiments further confirmed that [
F]10 accumulated in the DAT-rich region of the striatum.
[
F]10 is a highly promising metabolically stable
F-labeled PET probe for DAT imaging, with potential clinical applications in detecting and monitoring DAT-related neurological disorders.
